|
|
Thread Tools | Display Modes |
#1
|
|||
|
|||
[OT] Vioxx taken off the market
For any of you old fogeys (or, like me,
rapidly-approaching-middle-age-with-some-bumps-and-bruises-along-the-way- fogeys), heads up. It appears that Merck has taken Vioxx off the market amid concerns about cardiovascular complications - increased risk of stroke and heart attack in an 18-month study of cancer patients. I have to believe the risk extends beyond the limited field of chemo patients because Vioxx accounts for about 10% of Merck's sales - something like $2.5B per year - and they're doing this world-wide and NOT because the FDA or another country's regulatory agency is making them do it. I suspect that this cancer study made them go look at all the informal and anecdotal info they had and haven't released. They probably realized that if/when the FDA started the process to withdraw approval all that would become public, exposing them to risk of big fines and sanctions. So they did it first, to take the sting out a bit. Anyway, I've been taking this stuff for over two years and it's worked great for my L5-S1 disc injury. Time to call your docs and get a substitute 'scrip. Here's the CNN story: http://money.cnn.com/2004/09/30/news/fortune500/merck/index.htm -- Herb Schaltegger, B.S., J.D. "Never underestimate the power of human stupidity." ~ Robert A. Heinlein http://www.angryherb.net |
#2
|
|||
|
|||
On Thu, 30 Sep 2004 08:52:10 -0500, Herb Schaltegger
wrote: Anyway, I've been taking this stuff for over two years and it's worked great for my L5-S1 disc injury. Time to call your docs and get a substitute 'scrip. Bextra. My young internist changed me over to Bextra about a month ago, when the first reports about the Vioxx study came out. I asked him about cox-2 inhibiters in general and he said that he thought the concerns were a bit overblown, both regarding Vioxx and cox-2 inhibiters. He was changing patients over to Bextra because it worked better (and it does). Mary -- Mary Shafer Retired aerospace research engineer |
#3
|
|||
|
|||
In article ,
Mary Shafer wrote: On Thu, 30 Sep 2004 08:52:10 -0500, Herb Schaltegger wrote: Anyway, I've been taking this stuff for over two years and it's worked great for my L5-S1 disc injury. Time to call your docs and get a substitute 'scrip. Bextra. . . . (snip) Yep, that's what I ended up getting. I've been taking some samples from my doc for a few days while waiting for the mail-order prescription to arrive and it works great. -- Herb Schaltegger, B.S., J.D. "Never underestimate the power of human stupidity." ~ Robert A. Heinlein http://www.angryherb.net |
Thread Tools | |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
Return to moon: EELV or HLV? Let the market decide (or at least the buyers). | Alex Terrell | Policy | 39 | March 22nd 04 08:16 PM |
Prizes vs Market Guarantees | Len | Policy | 5 | February 20th 04 12:14 AM |
Too many Plossls on the market | Richard | Amateur Astronomy | 48 | January 18th 04 05:41 PM |
Space Market | nix.olimpica | Policy | 0 | December 4th 03 04:43 PM |
market size as a function of launcher size | Parallax | Policy | 12 | September 23rd 03 11:14 PM |